Recombinant multi-species CSNK2B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CSNK2B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the beta subunit of casein kinase II, a ubiquitous protein kinase which regulates metabolic pathways, signal transduction, transcription, translation, and replication. The enzyme is composed of three subunits, alpha, alpha prime and beta, which form a tetrameric holoenzyme. The alpha and alpha prime subunits are catalytic, while the beta subunit serves regulatory functions. The enzyme localizes to the endoplasmic reticulum and the Golgi apparatus. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
The Alternative Names of target: CK II beta,CK2B,CK2N,CSK2B,CSKN2B,CSNK2B,Casein kinase II subunit beta,Ck2,Ckb1,Ckb2,Csnk2b,G5A,POBINDS,Phosvitin,Protein G5a
Go
to CSNK2B products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP5742-Ag-1/ GM-Tg-hg-IP5742-Ag-2 | Human CSNK2B protein | Human |
| GM-Tg-rg-IP5742-Ag-1/ GM-Tg-rg-IP5742-Ag-2 | Rat CSNK2B protein | Rat |
| GM-Tg-mg-IP5742-Ag-1/ GM-Tg-mg-IP5742-Ag-2 | Mouse CSNK2B protein | Mouse |
| GM-Tg-cynog-IP5742-Ag-1/ GM-Tg-cynog-IP5742-Ag-2 | Cynomolgus/Rhesus macaque CSNK2B protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP5742-Ag-1/ GM-Tg-felg-IP5742-Ag-2 | Feline CSNK2B protein | Feline |
| GM-Tg-cang-IP5742-Ag-1/ GM-Tg-cang-IP5742-Ag-2 | Canine CSNK2B protein | Canine |
| GM-Tg-bovg-IP5742-Ag-1/ GM-Tg-bovg-IP5742-Ag-2 | Bovine CSNK2B protein | Bovine |
| GM-Tg-equg-IP5742-Ag-1/ GM-Tg-equg-IP5742-Ag-2 | Equine CSNK2B protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP5742-Ag-1/ GM-Tg-hg-IP5742-Ag-2;
GM-Tg-rg-IP5742-Ag-1/ GM-Tg-rg-IP5742-Ag-2;
GM-Tg-mg-IP5742-Ag-1/ GM-Tg-mg-IP5742-Ag-2; GM-Tg-cynog-IP5742-Ag-1/ GM-Tg-cynog-IP5742-Ag-2; GM-Tg-felg-IP5742-Ag-1/ GM-Tg-felg-IP5742-Ag-2; GM-Tg-cang-IP5742-Ag-1/ GM-Tg-cang-IP5742-Ag-2; GM-Tg-bovg-IP5742-Ag-1/ GM-Tg-bovg-IP5742-Ag-2; GM-Tg-equg-IP5742-Ag-1/ GM-Tg-equg-IP5742-Ag-2 |
| Products Name | CSNK2B protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CSNK2B |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CSNK2B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.